Let’s get right to the point.
No one has time to wait for answers. That’s why we are developing QScout RLD (Rapid Leukocyte Differential). It reports a white blood cell count and differential at point of care in about 2 minutes from a drop of blood*.
News that counts.
AAD, BARDA Partner To Seek Earlier Detection Of Sepsis
Federal agency BARDA to help fund AAD’s advanced diagnostic development
AAD, developer of rapid diagnostic and data systems, today announced that it has been awarded a federal contract for the development of an innovative system for the earlier detection of severe infection, including sepsis.
Forget the hassle.
QScout RLD requires no lengthy machine startup time or sample prep. No wet reagents that need to be changed or disposed. No pumps. Only a drop of blood. It’s easy to use with minimal training.
See the difference.
It’s an imaging-based system not prone to the challenges of flow cytometry or the Coulter Principle. Cells are examined directly by a trained computer using AI instead of indirect measures like light scatter or electrical resistance, so there’s no re-gating.
If you’re an investigator interested in clinical trials, please contact us.